Kinetic and cardiovascular effects of acute topiramate dosing among non-treatment-seeking, methamphetamine-dependent individuals.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Progress in Neuro-psychopharmacology and Biological Psychiatry

• Publication date

  2007-03-30

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/J.PNPBP.2006.11.011PMID 17184890PMCID PMC1847340
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of acute topiramate dosing on methamphetamine-induced subjective mood.

  2007cited by this paper
• Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals.

  2007cited by this paper
• GABA and Glutamate receptors in the horizontal limb of diagonal band of Broca (hDB): effects on cardiovascular regulation

  2005cited by this paper
• ROLE OF THE CENTRAL NUCLEUS OF THE AMYGDALA IN THE CONTROL OF BLOOD PRESSURE: DESCENDING PATHWAYS TO MEDULLARY CARDIOVASCULAR NUCLEI

  2005cited by this paper
• Interaction of GABA and glutamate in the horizontal limb of diagonal band of Broca (hDB): role in cardiovascular responses.

  2005cited by this paper
• Isradipine decreases the hemodynamic response of cocaine and methamphetamine results from two human laboratory studies: results from two human laboratory studies.

  2005cited by this paper
• Safety of intravenous methamphetamine administration during treatment with bupropion

  2005cited by this paper
• Recent Advances in the Development of Treatments for Alcohol and Cocaine Dependence

  2005cited by this paper
• A comprehensive assessment of the safety of intravenous methamphetamine administration during treatment with selegiline.

  2005cited by this paper
• A pilot trial of topiramate for the treatment of cocaine dependence.

  2004cited by this paper
• Topiramate increases biochemical risk of nephrolithiasis

  2004cited by this paper
• Pathogenesis of Hypertension

  2003cited by this paper
• Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.

  2003cited by this paper
• Cardiovascular manifestations of substance abuse: part 2: alcohol, amphetamines, heroin, cannabis, and caffeine.

  2003cited by this paper
• Topiramate-Induced Nephrolithiasis

  2002cited by this paper
• Cardiovascular responses elicited by the "binge" administration of methamphetamine.

  2002cited by this paper
• Topiramate selectively attenuates nicotine‐induced increases in monoamine release

  2001cited by this paper
• Effects of Isradipine, a Dihydropyridine-Class Calcium Channel Antagonist, on D-Methamphetamine-Induced Cognitive and Physiological Changes in Humans

  2000cited by this paper
• Isradipine, a dihydropyridine-class calcium channel antagonist, attenuates some of d-methamphetamine’s positive subjective effects: a preliminary study

  1999cited by this paper
• Urinary excretion of d-amphetamine following oral doses in humans: implications for urine drug testing.

  1998cited by this paper
• Modulation of Brain Dopamine Transmission by Sex Steroids

  1994cited by this paper
• Modulation of brain dopamine transmission by sex steroids.

  1994cited by this paper
• Clinical effects of daily methamphetamine administration.

  1991cited by this paper
• Effect of ovarian steroids to stimulate region-specific hypothalamic 5-hydroxytryptamine synthesis in ovariectomized rats.

  1986cited by this paper
• EFFECTS OF URINARY pH ON AMPHETAMINE METABOLISM

  1971cited by this paper

• Multiple comparison of different noninvasive brain stimulation and pharmacologic interventions in patients with methamphetamine use disorders: A network meta‐analysis of randomized controlled trials

  2022cites this paper
• Transcriptome profiling and pathway analysis of genes expressed differentially in participants with or without a positive response to topiramate treatment for methamphetamine addiction

  2014cites this paper
• Pharmacotherapy for Stimulant-Related Disorders

  2013cites this paper
• Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial.

  2012cites this paper
• AMPA receptor synaptic plasticity induced by psychostimulants: the past, present, and therapeutic future.

  2010cites this paper
• Pharmacological approaches to methamphetamine dependence: a focused review.

  2010cites this paper
• Pharmacotherapy of Methamphetamine Addiction: An Update

  2008cites this paper
• Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions.

  2008cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  2007cites this paper
• Review Ampa Receptor Synaptic Plasticity Induced by Psychostimulants: the Past, Present, and Therapeutic Future Glua1-containing Glua2-lacking Naive Early Withdrawal Late Withdrawal

  year unknowncites this paper